Vertex Pharmaceuticals Inc (VRTX :)

LATEST ABOUT THIS TOPIC ON CNBC.COM

• More

• Many in U.S. don't get proper testing for hepatitis C- CDC 07 May 2013 - AFX
• RESEARCH ALERT-Vertex Pharmaceuticals: UBS raises target price 01 May 2013 - AFX
• US Stocks Seen Down; Pfizer Earnings Awaited 30 Apr 2013 - CNBC.com
• Top Undervalued Pharma Stock: Analyst 29 Apr 2013 - CNBC.com
• Wednesday's Earnings Scorecard   24 Apr 2013
• Lightning Round   23 Apr 2013
• Mad Money, April 23, 2013   23 Apr 2013

MORE FROM CNBC

• More

• US Stocks Seen Down; Pfizer Earnings Awaited 30 Apr 2013 - CNBC.com
• Top Undervalued Pharma Stock: Analyst 29 Apr 2013 - CNBC.com
• Wednesday's Earnings Scorecard   24 Apr 2013
• Lightning Round   23 Apr 2013
• Mad Money, April 23, 2013   23 Apr 2013

MORE FROM OUR PARTNERS

• More

• This Stock Deserved Its Sudden Upswing 13 May 2013 - Seeking Alpha
• Vertex Debt Conversion Is Not Bad For Shareholders 09 May 2013 - Seeking Alpha
• Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential 03 May 2013 - Seeking Alpha
• Vertex Pharmaceuticals Beats Analyst Expectations, Yet Insiders Contin... 03 May 2013 - Seeking Alpha
• Why BioMarin, Catalyst Pharmaceutical Partners And Vertex Are Expected... 01 May 2013 - Seeking Alpha
• NewLink Genetics: Looking To Join The Industry's Largest Movers 29 Apr 2013 - Seeking Alpha
• Cramer's Lightning Round - EMC Is Controversial (4/23/13) 24 Apr 2013 - Seeking Alpha
• Vertex Spikes On Phase II Data, Then The CFO Sell His Shares 24 Apr 2013 - Seeking Alpha
• Catalyst Deserves The Attention 23 Apr 2013 - Seeking Alpha
• Today's Market News To Trade On: 5 Stocks Moving On News 22 Apr 2013 - Seeking Alpha

LATEST TRANSCRIPTS

• More

• Vertex Pharmaceuticals Incorporated Management Discusses Q1 2013 Resul... 30 Apr 2013 - Seeking Alpha

PRESS RELEASES

• More

• Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientifi... 3 hrs ago - Business Wire
• Medivir: Primary efficacy and safety findings from phase III study of ... 21 May 2013 - Business Wire
• Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's S... 21 May 2013 - PR Newswire
• Tens of Thousands to Walk for a Cure for Cystic Fibrosis 17 May 2013 - PR Newswire
• Vertex Calls for Redemption of $400 Million in Convertible Senior Subo... 17 May 2013 - Business Wire
• Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two ... 09 May 2013 - Business Wire
• Lux Capital Adds Bilal Zuberi as Partner 09 May 2013 - Business Wire
• Vertex Reports First Quarter 2013 Financial Results and Reviews Recent... 30 Apr 2013 - Business Wire
• Vertex Announces New Data that Showed High Viral Cure Rates with a Tot... 24 Apr 2013 - Business Wire
• Netflix Indicating Big Jump Pre-Market on Earnings Surprise - Top Earn... 23 Apr 2013 - PR Newswire

• 

  Sex or Smartphone? Women Prefer the Gadget

• US Home Sales at Highest Level in More Than 3 Years
• Bernanke: Too Soon to Taper Bond Buys
• Gotta Give Her Credit: Women Score Better on Debt
• Don't Expect Bernanke to Talk Taper...Yet: Pro
• Target Earnings Beat, but Sales Decline
• SAP Puts Faith in Autistic Tech Specialists
• Microsoft Xbox Takes on Apple, Google With Smart TV
• The Market Rally Has to Stop Sometime. Doesn't It?
• No Break for You: Automakers Rev Up Production

• Download Free Annual Report.